Thanks. I feel like I'm back to being glad I have
Post# of 36537
I'm under $0.50/sh average, so I know I'm better off than a lot of LT investors here. But, as I've always said, we're either going to $0, or we're going to be big. It looks promising that the $0 case is dwindling for now. So hopefully even those at $2 cost avg will be happy shortly.
The usual caveat... if we continue to get deals AND peptide/blood work success and/or a successful, lasting NGIO listing. This could be a difficult path again if they can't get the vaccine worked out as planned (up-front money returned, etc.) So we're not totally out of the woods, but we are certainly huge steps forward from where we were a couple of months ago, or even a week ago!